By Josh White
Date: Monday 13 Mar 2023
LONDON (ShareCast) - (Sharecast News) - Life science company Avacta reassured the market on Monday, following the collapse of technology and science-focussed Silicon Valley Bank last week.
The AIM-traded form said it had no banking relationship with either SVB or its local operation SVB UK.
As a result, it had no cash on deposit with them.
At 0951 GMT, shares in Avacta Group were down 1.34% at 135.66p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 45.05p |
Change Today | -0.26p |
% Change | -0.56 % |
52 Week High | 159.60 |
52 Week Low | 44.50 |
Volume | 1,371,996 |
Shares Issued | 359.04m |
Market Cap | £161.73m |
RiskGrade | 461 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 2 |
Neutral | 0 |
Sell | 1 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
10:27 | 75,000 @ 44.92p |
10:27 | 6,598 @ 45.35p |
10:27 | 44,445 @ 45.00p |
10:16 | 40,000 @ 45.34p |
10:15 | 4 @ 45.48p |
CEO | Alastair Smith |
CFO | Tony Peter Gardiner |
You are here: research